We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$183B
AUM Growth
-$41.5B
Cap. Flow
-$8B
Cap. Flow %
-4.38%
Top 10 Hldgs %
23.66%
Holding
10,385
New
1,237
Increased
3,761
Reduced
3,800
Closed
1,371

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$783M
2
MS icon
Morgan Stanley
MS
+$518M
3
LOW icon
Lowe's Companies
LOW
+$474M
4
V icon
Visa
V
+$425M
5
NFLX icon
Netflix
NFLX
+$419M

Sector Composition

Rank Sector Weight
1 Financials 5.01%
2 Technology 4.76%
3 Consumer Discretionary 3.82%
4 Industrials 3.81%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAT
8701
DELISTED
TransAtlantic Petroleum LTD.
TAT
$14K ﹤0.01%
+13,521
New +$16.1K
CLDX icon
8702
CALL
Celldex Therapeutics
CLDX
$3.28B
$13K ﹤0.01%
+4,420
New +$21.7K
IMUX icon
8703
Immunic
IMUX
$223M
$13K ﹤0.01%
177
-565
-76% -$66.1K
INUV icon
8704
Inuvo
INUV
$12.8M
$13K ﹤0.01%
1,248
-5,141
-80% -$46.2K
NTZ
8705
Natuzzi
NTZ
$14.3M
$13K ﹤0.01%
3,271
-587
-15% -$3.15K
PLX icon
8706
CALL
Protalix BioTherapeutics
PLX
$180M
$13K ﹤0.01%
4,330
+2,510
+138% +$11.9K
PRTS icon
8707
CarParts.com
PRTS
$48.3M
$13K ﹤0.01%
+1,388
New +$17.4K
PXS icon
8708
Pyxis Tankers
PXS
$52.1M
$13K ﹤0.01%
3,193
-3,470
-52% -$19.6K
VANI icon
8709
Vivani Medical
VANI
$120M
$13K ﹤0.01%
601
+120
+25% +$3.82K
VIRX
8710
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$13K ﹤0.01%
917
+308
+51% +$12.6K
BIOL
8711
DELISTED
Biolase, Inc.
BIOL
$13K ﹤0.01%
+5
New +$16.1K
TRVN
8712
PUT
DELISTED
Trevena, Inc.
TRVN
$13K ﹤0.01%
49
-11
-18% -$6.21K
KSPN
8713
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$13K ﹤0.01%
1,045
+472
+82% +$8.84K
OIG
8714
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$13K ﹤0.01%
+263
New +$18.3K
AMPE
8715
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$13K ﹤0.01%
108
-1
-0.9% -$153
RESN
8716
DELISTED
Resonant Inc.
RESN
$13K ﹤0.01%
+10,358
New +$25.3K
UUUU.WS
8717
DELISTED
Energy Fuels Inc.
UUUU.WS
$13K ﹤0.01%
10,484
-10,948
-51% -$15K
AXAS
8718
PUT
DELISTED
Abraxas Petroleum Corp
AXAS
$13K ﹤0.01%
+595
New +$20.7K
ANFI
8719
CALL
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$13K ﹤0.01%
30,300
+14,900
+97% +$11.4K
SDT
8720
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
$13K ﹤0.01%
16,358
-7,294
-31% -$7.83K
EPE
8721
PUT
DELISTED
EP Energy Corporation
EPE
$13K ﹤0.01%
18,900
-12,100
-39% -$18.1K
NAVB
8722
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$13K ﹤0.01%
6,475
-220
-3% -$907
CPAH
8723
DELISTED
Counterpath Corp
CPAH
$13K ﹤0.01%
+11,045
New +$21.2K
GLOWE
8724
DELISTED
GLOWPOINT INC
GLOWE
$13K ﹤0.01%
104,000
-61,423
-37% -$7.68K
YDKG
8725
Yueda Digital Holding
YDKG
$5.97M
$12K ﹤0.01%
+24
New +$15.8K

Similar funds

Citadel Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Citadel Advisors held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Assurant worth $99.4M.

  • Citadel Advisors's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
  • Citadel Advisors added most to Amazon in Q4 2018, an estimated $1.68B increase.
  • Citadel Advisors's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
  • Citadel Advisors fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
  • Citadel Advisors's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
  • Citadel Advisors opened 1,237 new positions and closed 1,371 in Q4 2018.
  • Citadel Advisors's portfolio value fell 19% quarter-over-quarter to $183B.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.